Gregory Seitz
Dermatology · Cheyenne, WYNPI 1962676353
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by LEO Pharma Inc. at 53.0% of the total. Reporting peaked in 2024 at $1,302 and has fallen 75.8% since, to $314 in 2025.
Across 46 payments — averaging $43.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$1K
- Johnson & Johnson$179
- Novartis$132
- Arcutis Biotherapeutics, Inc.$104
- AbbVie$94
- Galderma Laboratories, L.p.$93
- plus $338 from 11 others
What the payments were for
- Consulting fees$95048%
- Food & beverage$79039%
- Education$26013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 6 | $1,061 |
| Johnson & Johnson | 3 | $179 |
| Novartis | 6 | $132 |
| Arcutis Biotherapeutics, Inc. | 4 | $104 |
| AbbVie | 5 | $94 |
| Galderma Laboratories, L.p. | 5 | $93 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Lilly USA, LLC | 3 | $58 |
| Dermavant Sciences, Inc. | 3 | $52 |
| Amgen | 2 | $28 |
| Springworks Therapeutics, Inc. | 1 | $25 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Pfizer | 1 | $15 |
| Journey Medical Corporation | 1 | $15 |
| Organon | 2 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADBRY$950
How this compares
Too few dermatology providers in Wyomingto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 16 | $103,759 |
| RinvoqUpadacitinib | 14 | $85,126 |
| OpzeluraRuxolitinib Phosphate | 15 | $29,821 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 14 | $7,718 |
| Tacrolimus | 33 | $6,332 |
| Clobetasol Propionate | 69 | $4,924 |
| Doxycycline Hyclate | 110 | $2,231 |
| Clindamycin Phosphate | 34 | $1,747 |
| Mometasone Furoate | 71 | $1,523 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 53 | $1,251 |
| Triamcinolone Acetonide | 124 | $1,179 |
| Ketoconazole | 49 | $944 |
| Imiquimod | 36 | $832 |
| Pentoxifylline | 16 | $568 |
| Ciclopirox | 11 | $344 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $94 | $85,12614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few dermatology providers in Wyomingon file to place this against a meaningful peer group, so we don't.
Other dermatology in Cheyenne
- Krystal MasseyCheyenne$9K
- Sandra SurbruggCheyenne$2K
- Julie NevilleCheyenne$1K
- Mary ColeCheyenne$957
- Samuel EckerLaramie$3K
- Tyler QuestCasper$2K
- Matthew GreenCasper$2K
- Scott BennionCasper$2K
- Melissa RhoadesGillette$2K
- Jonathan BakerJackson$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.